Printer Friendly

EMR for the long haul.

If you've been wondering what the number one reason is for low adoption rates of electronic medical records (EMR) by physicians, or how to overcome EMR "go-live" myopia, or even how the American Recovery and Reinvestment Act (ARRA) might transform EMR acceptance, "Beyond Implementation: A Prescription for Lasting EMR Adoption" has the answers. This new, 132-page soft-cover book by Dr. Heather Haugen and Dr. Jeffrey Woodside aims to get at the heart of the matter: Why is EMR adoption so costly, lengthy and frustrating?

Haugen and Woodside feel your pain.

The duo tackles everything from workplace dynamics ("How Leaders Create a 'Tone at the Top'") to the numbers game ("Performance Metrics and Adoption"), all with the long-term goal of reaching EMR sustainability in your enterprise.

Dr. Heather Haugen earned her doctorate in health information technology from the University of Colorado Health Sciences Center and is the corporate vice president of research for healthcare IT consulting firm The Breakaway Group. Dr. Jeffrey R. Woodside earned his medical degree from the University of Oregon Medical School and is the former executive vice president and chief medical officer for UT Medical Group. Combined, the two have more than 45 years of research, practice and corporate medical experience.

Published by Magnusson Skor, this $15.99 title is available at www.BeyondImplementation.org and www.Amazon.com.

COPYRIGHT 2010 Nelson Publishing
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2010 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:electronic medical records
Publication:Health Management Technology
Article Type:Brief article
Geographic Code:1USA
Date:Aug 1, 2010
Words:222
Previous Article:CHIME supports changes incorporated into final meaningful use rule: concerns remain regarding aggressive Stage 1 objectives.
Next Article:Allscripts to buy Eclipsys in $1.3 billion all-share deal.
Topics:

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters |